SHENZHEN RUILIANXING TECHNOLOGY CO., LTD – Trademark Portfolio

Entity Type: 16

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LIFEWIT. The owner is based in SHENZHEN.

1ST FLOOR, NO. 5, QUESHAN XINERCUN

INDUSTRIAL, ZONE, GAOFENG COMMUNITY, DALANG STREET, LONGHUA, DISTRICT,

SHENZHEN 518109 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIFEWIT
LIFEWIT
Registered 2019

Trademark Classifications

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN RUILIANXING TECHNOLOGY CO., LTD have?

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN RUILIANXING TECHNOLOGY CO., LTD file in?

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN RUILIANXING TECHNOLOGY CO., LTD's most well-known trademarks?

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as LIFEWIT. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN RUILIANXING TECHNOLOGY CO., LTD's trademark registration success rate?

SHENZHEN RUILIANXING TECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.